Bioverge Funds, Thryve I, a series of Bioverge Funds II, LLC — Form D
Bioverge Funds, Thryve I, a series of Bioverge Funds II, LLC of Salt Lake City, UT, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-11-12. The offering totals $113K, of which $113K was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-11-12
- Form: D
- Accession: 0001792733-19-000003
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C.1
- Total offering: $113K
- Amount sold: $113K
- Minimum investment: $5K
- Investors: 15
- Date of first sale: 2019-11-01
- Security types: fund interests
- SEC file number: 021-353147
Issuer
- Name: Bioverge Funds, Thryve I, a series of Bioverge Funds II, LLC
- CIK: 0001789403
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 6510 S Millrock Drive, Salt Lake City, UT, 84121
- Phone: (801) 419-0677
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| LLC Assure Fund Management II | Director | Salt Lake City, UT |
| Jeremy Neilson | Executive Officer | Salt Lake City, UT |
| Richard Thoms | Executive Officer | Salt Lake City, UT |
More